Infection and Chemotherapy最新文献

筛选
英文 中文
Epidemiological and Clinical Characteristics of Women Living with HIV in Korea. 韩国女性艾滋病感染者的流行病学和临床特征。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 DOI: 10.3947/ic.2024.0057
Sang Min Ahn, Yong Seop Lee, Min Han, Jung Ah Lee, Jae Eun Seong, Yae Jee Baek, JongHoon Hyun, Jung Ho Kim, Jin Young Ahn, Dong Hyun Oh, Su Jin Jeong, Ji Hyeon Baek, Nam Su Ku, Hee Kyoung Choi, Yoonseon Park, BumSik Chin, Young Keun Kim, Joon Sup Yeom, Young Hwa Choi, Jun Yong Choi
{"title":"Epidemiological and Clinical Characteristics of Women Living with HIV in Korea.","authors":"Sang Min Ahn, Yong Seop Lee, Min Han, Jung Ah Lee, Jae Eun Seong, Yae Jee Baek, JongHoon Hyun, Jung Ho Kim, Jin Young Ahn, Dong Hyun Oh, Su Jin Jeong, Ji Hyeon Baek, Nam Su Ku, Hee Kyoung Choi, Yoonseon Park, BumSik Chin, Young Keun Kim, Joon Sup Yeom, Young Hwa Choi, Jun Yong Choi","doi":"10.3947/ic.2024.0057","DOIUrl":"10.3947/ic.2024.0057","url":null,"abstract":"<p><strong>Background: </strong>While Korea maintains a low prevalence of human immunodeficiency virus (HIV), the number of newly diagnosed cases has been steadily rising, reaching approximately 1,000 annually in recent years. The 2022 annual report from the Korea Disease Control and Prevention Agency revealed that women living with HIV (WLWH) constitute 6.4% of the total confirmed people living with the HIV population, totaling 1,219 individuals. Despite this, only a few studies have focused on WLWH in Korea. This study aims to analyze the epidemiological and clinical characteristics of WLWH in Korea.</p><p><strong>Materials and methods: </strong>We retrospectively collected data by reviewing the medical records of all WLWH who visited 10 urban referral hospitals across Korea between January 2005 and May 2023.</p><p><strong>Results: </strong>A total of 443 WLWH were enrolled in this study. The predominant risk exposure was heterosexual contact, with 235 (53%) participants either married or cohabiting with a male partner at their initial clinic visit. Among the participants, 334 (77.7%) were Korean, 27 (6.1%) were Southeast Asian, and 19 (4.3%) were African. Antiretroviral therapy was initiated by 404 WLWH (91.2%). We observed 118 pregnancies in WLWH following their HIV diagnosis, resulting in 78 live births (66.1%), 18 induced abortions (15.2%), 10 pre-viable fetal losses (8.5%), and four stillbirths (3.4%). Over a cumulative follow-up duration of 3,202.1 years, the incidence rates of breast and cervical cancers were both 2.18 per 1,000 person-years. Additionally, the incidence rates of pelvic inflammatory disease, cervical intraepithelial neoplasm (above grade II), and osteoporosis were 4.67, 11.21, and 13.39 per 1,000 patient-years, respectively.</p><p><strong>Conclusion: </strong>This is the first multicenter study to investigate the clinical and epidemiological characteristics of WLWH in Korea. The incidence and prevalence of diseases in women, including breast cancer, cervical cancer, and chronic comorbidities, are high in WLWH in Korea; therefore, further research and efforts are needed to manage these diseases.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 3","pages":"369-377"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possible Bioterrorism by North Korea and South Korea's Preparedness. 朝鲜可能实施的生物恐怖主义和韩国的准备工作。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 Epub Date: 2024-07-17 DOI: 10.3947/ic.2024.0068
Kun Hwang
{"title":"Possible Bioterrorism by North Korea and South Korea's Preparedness.","authors":"Kun Hwang","doi":"10.3947/ic.2024.0068","DOIUrl":"10.3947/ic.2024.0068","url":null,"abstract":"<p><p>This paper reviews the elements and infection mechanisms of bioterrorism, assess North Korea's capability for biological warfare, and propose strategies for South Korea to counter potential bioterrorist threats from the North. The four critical elements of bioterrorism include the biological agent, the weaponization of the agent, the delivery system, and the impact of weather conditions on the attack. The infection routes for biological agents in bioterrorism include inhalation, ingestion, dermal exposure, and injection. The potential agents under development could include anthrax, smallpox, plague, and botulinum toxin, which might be deployed using missiles, artillery shells, or through covert operations. Proximity to North Korea significantly increases vulnerability to biological attacks. Possible methods include contaminating water supplies, food sources, or densely populated areas. Anthrax, smallpox, plague, and botulinum toxin could theoretically be delivered using packages attached to balloons. Minimizing the impact of a bioterrorism event requires strategy that includes four key actions: detection, decision-making, distribution, and dispensation. By integrating these steps, authorities can effectively manage and mitigate the effects of a bioterrorism event. Civilian doctors play a role in the early detection, diagnosis, treatment, and management of biological agents. Educating medical professionals is crucial for preparing against potential biological warfare or bioterrorism threats.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"300-307"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141890878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Response to Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study. 回复:COVID-19对住院的实体器官移植受者临床结果的影响:倾向得分匹配队列研究。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 DOI: 10.3947/ic.2024.0076
Eunkyung Nam, Jeong-Hoon Lim, Ki Tae Kwon
{"title":"Reply: Response to Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study.","authors":"Eunkyung Nam, Jeong-Hoon Lim, Ki Tae Kwon","doi":"10.3947/ic.2024.0076","DOIUrl":"10.3947/ic.2024.0076","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 3","pages":"417-418"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiretroviral Therapy during Long-term Surgical Care: 'Exploring Difficult Cases in HIV Clinics' of the Korean Society for AIDS Conference in 2023. 长期外科护理期间的抗逆转录病毒疗法:2023 年韩国艾滋病学会大会的 "艾滋病临床疑难病例探讨"。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 Epub Date: 2024-08-01 DOI: 10.3947/ic.2024.0052
Jung Ho Kim, Jae Eun Seong, Sangmin Ahn, Yongseop Lee, Jung Ah Lee, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Joon-Sup Yeom, Jun Yong Choi
{"title":"Antiretroviral Therapy during Long-term Surgical Care: 'Exploring Difficult Cases in HIV Clinics' of the Korean Society for AIDS Conference in 2023.","authors":"Jung Ho Kim, Jae Eun Seong, Sangmin Ahn, Yongseop Lee, Jung Ah Lee, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Joon-Sup Yeom, Jun Yong Choi","doi":"10.3947/ic.2024.0052","DOIUrl":"10.3947/ic.2024.0052","url":null,"abstract":"<p><p>With advancements in antiretroviral therapy (ART), the average lifespan of people with human immunodeficiency virus (HIV) is increasing, as is the number of older adults with HIV. Accordingly, the number of patients with HIV who undergo surgery or require critical care for various reasons is increasing. Since the prognosis of people with HIV depends on the continuous and effective maintenance of ART, there is a need to consider effectively maintaining ART in people with HIV in these conditions. This case involved a 55-year-old patient with well-controlled HIV who received ART and presented to the emergency room with acute abdominal pain. He was diagnosed with extensive bowel infarction and panperitonitis and received critical care in the intensive care unit, including mechanical ventilation and continuous renal replacement therapy. The patient was administered enteral nutrition via a nasogastric tube. The patient subsequently underwent extensive small bowel resection and developed short bowel syndrome. The patient maintained ART during that period. A literature review related to the use of ART under these conditions is included in this study. This case was discussed at the [Exploring Difficult Cases in HIV Clinics] of the Korean Society for AIDS Conference held in 2023.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"287-299"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: SARS-CoV-2 Transmission Rate Depends on Infectivity of the Virus Strain, Closeness of Contact, and the Immune Competence of the Infected Person. 回复:SARS-CoV-2 的传播率取决于病毒株的感染性、接触的密切程度和感染者的免疫能力。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 Epub Date: 2024-08-16 DOI: 10.3947/ic.2024.0082
Jiwoo Sim, Euncheol Son, Young June Choe
{"title":"Reply to: SARS-CoV-2 Transmission Rate Depends on Infectivity of the Virus Strain, Closeness of Contact, and the Immune Competence of the Infected Person.","authors":"Jiwoo Sim, Euncheol Son, Young June Choe","doi":"10.3947/ic.2024.0082","DOIUrl":"10.3947/ic.2024.0082","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"421-422"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply: Response to Six-Year Study on Cutaneous Leishmaniasis in Al-Muthanna, Iraq: Molecular Identification Using ITS1 Gene Sequencing. 答复:对伊拉克穆萨纳皮肤利什曼病六年研究的回应:使用 ITS1 基因测序进行分子鉴定。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 DOI: 10.3947/ic.2024.0093
Mohammed H Flaih, Enas R Alwaily, Alyaa A Hafedh, Khwam R Hussein
{"title":"Reply: Response to Six-Year Study on Cutaneous Leishmaniasis in Al-Muthanna, Iraq: Molecular Identification Using ITS1 Gene Sequencing.","authors":"Mohammed H Flaih, Enas R Alwaily, Alyaa A Hafedh, Khwam R Hussein","doi":"10.3947/ic.2024.0093","DOIUrl":"10.3947/ic.2024.0093","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 3","pages":"413-414"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458501/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infection & Chemotherapy: The Experience of Journal Integration and Future Prospects. 感染与化疗》:期刊整合的经验与未来展望》。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 DOI: 10.3947/ic.2024.0106
Dong-Gun Lee
{"title":"<i>Infection & Chemotherapy</i>: The Experience of Journal Integration and Future Prospects.","authors":"Dong-Gun Lee","doi":"10.3947/ic.2024.0106","DOIUrl":"10.3947/ic.2024.0106","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 3","pages":"409-410"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis. 基于 INI 的 2 种药物疗法对病毒抑制型 HIV 感染者的疗效和耐受性:系统回顾与元分析》。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 DOI: 10.3947/ic.2024.0066
Antonio Russo, Salvatore Martini, Mariantonietta Pisaturo, Maria Grazia Palamone, Maria Teresa Russo, Verdiana Zollo, Roberta Palladino, Pierantonio Grimaldi, Alberto Borghetti, Giuseppe Vittorio De Socio, Massimiliano Fabbiani, Nicola Coppola
{"title":"Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis.","authors":"Antonio Russo, Salvatore Martini, Mariantonietta Pisaturo, Maria Grazia Palamone, Maria Teresa Russo, Verdiana Zollo, Roberta Palladino, Pierantonio Grimaldi, Alberto Borghetti, Giuseppe Vittorio De Socio, Massimiliano Fabbiani, Nicola Coppola","doi":"10.3947/ic.2024.0066","DOIUrl":"10.3947/ic.2024.0066","url":null,"abstract":"<p><strong>Background: </strong>The aim of this meta-analysis was to synthesize the available evidence from the literature on the efficacy and safety of integrase inhibitor-based two drug regimens compared to triple drug regimens in virosuppressed people living with HIV (PLWH) in a long-term follow-up (at 96 weeks).</p><p><strong>Materials and methods: </strong>A systematic review and meta-analysis were conducted to evaluate the efficacy, safety, and adverse drug reactions leading to discontinuation of two drug regimens compared to triple drug regimens in virosuppressed PLWH patients at 96 weeks of follow-up. We searched MEDLINE, Google Scholar, and the Cochrane Library up to March 15, 2024, and studies were selected for eligibility based on predefined criteria. Data were extracted independently by two reviewers, and risk ratios (RRs) were calculated as the measure of association between therapy and incidence of events.</p><p><strong>Results: </strong>Six studies were included in the analysis, both clinical trials and observational studies. The two drug regimens included cabotegravir/rilpivirine, dolutegravir/lamivudine, and dolutegravir/rilpivirine. No significant differences were observed in treatment failure (RR, 0.77; 95% confidence interval [CI], 0.53-1.13; <i>P</i>=0.182), virological failure (RR, 0.79; 95% CI, 0.48-1.29; <i>P</i>=0.341), adverse drug reactions leading to discontinuation (RR, 1.74; 95% CI, 0.73-4.17; <i>P</i>=0.215), or appearance of mutation (RR, 2.48; 95% CI, 0.33-18.68; <i>P</i>=0.379) between two drug regimen and triple drug regimen groups at 96 weeks of follow up.</p><p><strong>Conclusion: </strong>The meta-analysis provide an overview of the available evidence and supports the use of two drug regimens as an option for simplifying treatment and improving clinical outcomes in virosuppressed PLWH.</p>","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":"56 3","pages":"395-405"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study. 使用 COVID-19 住院的实体器官移植受者对临床结果的反应:倾向得分匹配队列研究。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-09-01 Epub Date: 2024-08-16 DOI: 10.3947/ic.2024.0064
Sudip Bhattacharya
{"title":"Response to Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study.","authors":"Sudip Bhattacharya","doi":"10.3947/ic.2024.0064","DOIUrl":"10.3947/ic.2024.0064","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"415-416"},"PeriodicalIF":2.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Usefulness of the Rapid Antigen Test in Detecting SARS-CoV-2 for Infection Control in Hospitals. 对快速抗原检测在医院感染控制中检测 SARS-CoV-2 的有用性的回应。
IF 2.8
Infection and Chemotherapy Pub Date : 2024-06-01 Epub Date: 2024-05-13 DOI: 10.3947/ic.2024.0035
Sudip Bhattacharya
{"title":"Response to Usefulness of the Rapid Antigen Test in Detecting SARS-CoV-2 for Infection Control in Hospitals.","authors":"Sudip Bhattacharya","doi":"10.3947/ic.2024.0035","DOIUrl":"10.3947/ic.2024.0035","url":null,"abstract":"","PeriodicalId":51616,"journal":{"name":"Infection and Chemotherapy","volume":" ","pages":"282-283"},"PeriodicalIF":2.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141302006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信